Back to Journals » Psoriasis: Targets and Therapy » Volume 13 » default
Psoriasis: Targets and Therapy
ISSN: 2230-326X
- View all (141)
- Volume 14, 2024 (8)
- Volume 13, 2023 (7)
- Volume 12, 2022 (22)
- Volume 11, 2021 (14)
- Volume 10, 2020 (8)
- Volume 9, 2019 (13)
- Volume 8, 2018 (12)
- Volume 7, 2017 (9)
- Volume 6, 2016 (15)
- Volume 5, 2015 (13)
- Volume 4, 2014 (5)
- Volume 3, 2013 (4)
- Volume 2, 2012 (10)
- Volume 1, 2011 (1)
Archive: Volume 13, 2023
The Skin Microbiome and Its Role in Psoriasis: A Review
Celoria V, Rosset F, Pala V, Dapavo P, Ribero S, Quaglino P, Mastorino L
Psoriasis: Targets and Therapy 2023, 13:71-78
Published Date: 26 October 2023
Management of Plaque Psoriasis in Adults: Clinical Utility of Tapinarof Cream
Spencer RK, Jin JQ, Elhage KG, Davis MS, Liao W, Bhutani T
Psoriasis: Targets and Therapy 2023, 13:59-69
Published Date: 25 October 2023
Palmoplantar Pustulosis: A Systematic Review of Risk Factors and Therapies
Heidemeyer K, May Lee M, Cazzaniga S, Yawalkar N, Naldi L
Psoriasis: Targets and Therapy 2023, 13:33-58
Published Date: 22 September 2023
Therapeutic Management of a Case of Severe Psoriasis Coexistent with Bullous Pemphigoid in the Elderly
Di Lernia V, Peccerillo F, Ficarelli E
Psoriasis: Targets and Therapy 2023, 13:27-31
Published Date: 22 August 2023
Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature
Potestio L, Ruggiero A, Fabbrocini G, Martora F, Megna M
Psoriasis: Targets and Therapy 2023, 13:19-26
Published Date: 4 May 2023
Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis
Potestio L, Martora F, Fabbrocini G, Battista T, Megna M
Psoriasis: Targets and Therapy 2023, 13:11-18
Published Date: 12 April 2023
Analysis of Drug Utilization in Patients with Psoriasis: A Real-World Retrospective Study Among the Italian Population
Perrone V, Losi S, Sabatino S, Mezzetti M, Dovizio M, Sangiorgi D, Degli Esposti L
Psoriasis: Targets and Therapy 2023, 13:1-9
Published Date: 2 March 2023